Clinical uses of nalidixic acid analogues: the fluoroquinolones.
D000284:Administration, Oral; D000890:Anti-Infective Agents / Q000378:metabolism / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy*; D002939:Ciprofloxacin / Q000031:analogs & derivatives; D004341:Drug Evaluation; D004352:Drug Resistance, Microbial; D015365:Enoxacin; D024841:Fluoroquinolones; D006801:Humans; D008297:Male; D009268:Nalidixic Acid / Q000031:analogs & derivatives*; D009287:Naphthyridines / Q000378:metabolism / Q000627:therapeutic use*; D009643:Norfloxacin / Q000031:analogs & derivatives / Q000378:metabolism / Q000627:therapeutic use; D015242:Ofloxacin; D010078:Oxazines / Q000378:metabolism / Q000627:therapeutic use; D015366:Pefloxacin; D011804:Quinolines / Q000378:metabolism / Q000627:therapeutic use*; D059005:Topoisomerase II Inhibitors
D000890:Anti-Infective Agents; D024841:Fluoroquinolones; D009287:Naphthyridines; D010078:Oxazines; D011804:Quinolines; D059005:Topoisomerase II Inhibitors; D015366:Pefloxacin; D015365:Enoxacin; D009268:Nalidixic Acid; D002939:Ciprofloxacin; C040691:amifloxacin; D015242:Ofloxacin; D009643:Norfloxacin